Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

This article is for informational purposes only and does not constitute investment advice. Always do your own research and consider consulting a licensed financial adviser before making investment decisions. CYPH Stock Today: Pre‑Market Surge Keeps the Story in the Spotlight Cypherpunk Technologies Inc. (NASDAQ: CYPH) is back on traders’ radar this Monday, 17 November 2025, as the stock extends last week’s explosive move following its dramatic pivot from cancer‑drug biotech Leap Therapeutics into a Zcash‑focused digital asset treasury company. In U.S. pre‑market trading, Benzinga’s movers report lists Cypherpunk among the top healthcare gainers, with shares recently up more than 30%
17 November 2025
·
Genius Group (GNS) Soars on Market‑Manipulation Lawsuit: What Today’s 17 November 2025 Rally Really Means

Genius Group (GNS) Soars on Market‑Manipulation Lawsuit: What Today’s 17 November 2025 Rally Really Means

Genius Group Limited (NYSE American: GNS) is back in the spotlight today after its stock spiked more than 35–40% in U.S. pre‑market trading, driven by fresh attention on a newly filed $250 million federal securities class action lawsuit against Citadel Securities and Virtu Americas.Stocktwits+2Benzinga+2 By midday, the move has cooled but GNS is still trading around $0.86, up modestly on the session and with elevated volume, underscoring renewed retail interest in one of the market’s more controversial small‑cap education and Bitcoin plays. Stock Titan Below is everything investors and observers need to know about today’s move, the lawsuit, and how
17 November 2025
Jeff Bezos Returns to the CEO Seat: Inside Project Prometheus, the $6.2 Billion AI Manufacturing AI Startup

Jeff Bezos Returns to the CEO Seat: Inside Project Prometheus, the $6.2 Billion AI Manufacturing AI Startup

Amazon founder Jeff Bezos is stepping back into an operational role as co-CEO of Project Prometheus, a new AI startup with $6.2 billion in funding that aims to transform manufacturing for computers, cars, and spacecraft. Here’s what we know so far and why it matters. Jeff Bezos is back in the day-to-day game For the first time since stepping down as CEO of Amazon in July 2021, Jeff Bezos is preparing to run a company again — and it’s not Amazon, Blue Origin, or any existing arm of his empire. According to a report in The New York Times, relayed
17 November 2025
·
Dell Technologies (DELL) in Focus: AI Cloud Deal and Conflicting Analyst Calls – 17 Nov 2025

Dell Technologies (DELL) in Focus: AI Cloud Deal and Conflicting Analyst Calls – 17 Nov 2025

Dell Technologies Inc. (NYSE: DELL) saw volatile trading on November 17, 2025, as a rare Morgan Stanley double downgrade clashed with a fresh JPMorgan price-target hike and a new AI cloud infrastructure deal with HIVE Digital. Here’s what investors need to know today. DELL Stock Today: Volatility After a Rare Double Downgrade On Monday, November 17, Dell Technologies (NYSE: DELL) spent much of the session in the spotlight as traders digested a highly unusual double downgrade from Morgan Stanley alongside a fresh bullish note from JPMorgan. Over the last week, Dell has slid roughly 9–10%, and it is down about
17 November 2025
···
XPeng Stock (XPEV) Slides After Q3 2025 Earnings: Record Deliveries, Narrower Loss but Soft Q4 Guidance

XPeng Stock (XPEV) Slides After Q3 2025 Earnings: Record Deliveries, Narrower Loss but Soft Q4 Guidance

Chinese smart EV maker XPeng Inc. (NYSE: XPEV, HKEX: 9868) reported record third‑quarter 2025 results before the U.S. market open on Monday, but a cautious fourth‑quarter outlook and ongoing EV price wars weighed on investor sentiment, sending the stock lower in pre‑market trading. Stock Titan+1 Record Q3 2025: deliveries, revenue and margins all hit new highs XPeng’s headline numbers for the quarter ended September 30, 2025 show a company still firmly in hyper‑growth mode: On profitability metrics, XPeng delivered the kind of margin improvement investors have been waiting years to see: These gains came from a combination of scale, cost
17 November 2025
·
Datavault AI (DVLT) Jumps on Triton Tokenization Deal and Q3 Revenue Surge

Datavault AI (DVLT) Jumps on Triton Tokenization Deal and Q3 Revenue Surge

Datavault AI (NASDAQ: DVLT) announces a multi‑million dollar Triton Geothermal tokenization agreement and reports 148% year‑over‑year Q3 2025 revenue growth, lifting 2025–2026 guidance and sending DVLT stock sharply higher. Datavault AI’s Big Morning: New Deal, New Numbers, New Guidance Datavault AI Inc. (NASDAQ: DVLT) is back in the spotlight today, 17 November 2025, after dropping two major announcements before the opening bell: The market reaction has been immediate: as of early afternoon UTC, DVLT shares trade around $1.83, up roughly 18% on the day, extending a recent run that already saw the stock gain nearly 19% during Friday’s session. StockAnalysis
17 November 2025
····
Zymeworks (ZYME) Soars on Positive Phase 3 Ziihera Data in Gastric Cancer – What Today’s Breakthrough Means for the Stock and Patients

Zymeworks (ZYME) Soars on Positive Phase 3 Ziihera Data in Gastric Cancer – What Today’s Breakthrough Means for the Stock and Patients

What Zymeworks Announced Today Before the U.S. market open on November 17, 2025, Vancouver‑based Zymeworks Inc. (ZYME) released topline Phase 3 data from its pivotal HERIZON‑GEA‑01 study, evaluating Ziihera (zanidatamab‑hrii) in first‑line treatment of HER2‑positive locally advanced or metastatic gastroesophageal adenocarcinoma, a group that includes cancers of the stomach, gastroesophageal junction, and esophagus. GlobeNewswire+1 The trial compared three regimens: According to Zymeworks and its partners Jazz Pharmaceuticals and BeOne Medicines, HERIZON‑GEA‑01 delivered several key findings: GlobeNewswire+2GlobeNewswire+2 On the back of these data, Jazz plans to: GlobeNewswire+1 For Zymeworks, which originally discovered Ziihera using its Azymetric™ bispecific antibody platform, the company
17 November 2025
··
SanDisk (SNDK) Stock Rides AI Storage Wave as Tiny 1TB ‘Extreme Fit’ Drive Lands – 16 November 2025

SanDisk (SNDK) Stock Rides AI Storage Wave as Tiny 1TB ‘Extreme Fit’ Drive Lands – 16 November 2025

SanDisk is closing out the week with a potent mix of tiny hardware and big numbers. A new “plug‑and‑stay” 1TB USB‑C flash drive is hitting headlines today, while the company’s surging earnings, aggressive NAND price hikes, and fresh analyst upgrades keep SNDK front and center for investors. Below is a full rundown of what’s happening with SanDisk today, how it fits into the broader memory‑chip crunch, and what it means for SNDK shareholders. SanDisk’s new 1TB Extreme Fit drive goes viral today Photography and camera-gear site SonyAlphaRumors today highlighted SanDisk’s minuscule 1TB Extreme Fit USB‑C flash drive, calling out how
16 November 2025
··
Vistra Corp (VST) Stock News Today: Institutional Flows, Q3 Earnings and 2026 Outlook – 16 November 2025

Vistra Corp (VST) Stock News Today: Institutional Flows, Q3 Earnings and 2026 Outlook – 16 November 2025

As of Sunday, 16 November 2025, Vistra Corp. (NYSE: VST) sits at the heart of the AI‑driven power demand story, with fresh institutional moves, new forecasts and a still‑hot debate over valuation. Quick snapshot: Vistra today Despite pulling back about 22% from its 52‑week high, Vistra stock is still up roughly 35–40% over the past year, reflecting investors’ enthusiasm for its nuclear, gas and clean‑energy portfolio as AI and data‑center growth drive structural power‑demand increases. Investors+1 What changed for Vistra today (16 November 2025) Several fresh items dated 16 November 2025 are shaping the narrative around VST: 1. Waratah trims
16 November 2025
·
Is NIO (NYSE: NIO) Stock a Buy on 16 November 2025? Record Deliveries, Q4 Profit Push and Lawsuit Risks

Is NIO (NYSE: NIO) Stock a Buy on 16 November 2025? Record Deliveries, Q4 Profit Push and Lawsuit Risks

As of Sunday, 16 November 2025, NIO Inc. (NYSE: NIO) sits around $6.2 per share, roughly 20–25% below its early‑October 52‑week high of $8.02 but still well above this year’s lows near $3. CoinCodex Behind the volatile share price is a very mixed story: Here’s a detailed look at where NIO stands right now and what investors will be watching heading into its Q3 earnings release on 25 November 2025. Longbridge SG NIO Stock Today: Price, Momentum and Sentiment Multiple data providers put NIO’s latest price in the $6.1–$6.2 range, with a market cap in the low‑teens billions of dollars.
16 November 2025
Medical Properties Trust (MPW) Today: Rating Upgrade, Institutional Moves & Q3 Turnaround – 16 November 2025

Medical Properties Trust (MPW) Today: Rating Upgrade, Institutional Moves & Q3 Turnaround – 16 November 2025

Medical Properties Trust, Inc. (NYSE: MPW) remains one of the most closely watched high‑yield REITs on Wall Street. As of mid‑November 2025, the stock sits around the $5 mark, backed by a dividend yield of roughly 6–7% and a long list of past controversies involving distressed tenants like Steward Health Care and Prospect Medical.Digrin Today’s news cycle brings two fresh catalysts for MPW investors: At the same time, investors are still digesting MPW’s Q3 2025 results, released on October 30, which showed an improving cash‑collection picture but another GAAP net loss as the company works through legacy tenant issues.ir.medicalpropertiestrust.com+1 Key
16 November 2025
Waste Management (WM) Stock News Today: Institutional Buying Wave, ‘Moderate Buy’ Rating and New Recycling Push – 16 November 2025

Waste Management (WM) Stock News Today: Institutional Buying Wave, ‘Moderate Buy’ Rating and New Recycling Push – 16 November 2025

Waste Management, Inc. (NYSE: WM) draws fresh institutional inflows, a reaffirmed “Moderate Buy” analyst consensus and new recycling initiatives as of 16 November 2025. Houston / New York – 16 November 2025 – Waste Management, Inc. (WM), North America’s largest trash, recycling and environmental‑services company, is back in the spotlight this weekend after a flurry of analyst notes and institutional filings hit the tape. On Sunday, multiple new 13F updates and research pieces published by MarketBeat and other outlets show big money largely adding to WM, even as the stock trades about 14% below its 52‑week high following a slightly
16 November 2025
·
1 … 39 40 41 42 43 … 233

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop